A detailed history of Nixon Capital, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Nixon Capital, LLC holds 7,274 shares of FGEN stock, worth $2,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,274
Previous 7,274 -0.0%
Holding current value
$2,254
Previous $17.1 Million 62.03%
% of portfolio
0.0%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.38 - $0.91 $2,764 - $6,619
7,274 New
7,274 $6.45 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $29.1M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Nixon Capital, LLC Portfolio

Follow Nixon Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Capital, LLC with notifications on news.